Completed PHASE2 INTERVENTIONAL 2-arm NCT00041392

Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery (POINT)

PeriOperative Interventional Neuroprotection Trial (POINT)

Sponsor: Duke University

Conditions Cardiovascular Diseases Coronary Disease Heart Diseases Neurologic Manifestations

Updated 8 times since 2017 Last updated: Jul 25, 2013 Started: Dec 31, 2001 Primary completion: May 31, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cardiovascular Diseases and Coronary Disease, this trial is completed. The trial is conducted by Duke University and has accumulated 8 data snapshots since 2001. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Dec 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States